IMNN Stock Catalyst: Imunon Announces Acceptance of IMNN-001 Abstract for ESMO Gynaecological Cancers Congress 2025

May 27, 2025 · 10:40am ET

The abstract highlights data from the Phase 2 OVATION 2 Study.

Max move

+180.6%

High of day $31.30

Sparker timei

10:40am ET

IMNN · May 27, 2025

CATALYST DATE · 1-MINUTE BARS

Catalyst Summary

Imunon, Inc. announced on May 27, 2025 Imunon, Inc. announced that an abstract highlighting IMNN-001 data based on an immune biomarker analysis from the Phase 2 OVATION 2 Study in women with newly diagnosed advanced ovarian cancer was accepted for poster presentation at the European Society for Medical Oncology (ESMO) Gynaecological Cancers Congress 2025.

Imunon, Inc. Common Stock has a free float of 3,036,400 shares and 3,070,400 shares outstanding.

This summary was generated by AI from public sources and may contain errors. Not financial advice. Trade at your own risk.

Real-time alerts

Get notified the next time IMNN sparks.

Download Sniper App →

Catch the next IMNN-style move in real time.

Day Trader Sniper alerts you the moment a setup like this triggers: premarket, open, or intraday.

Watch demo Download Free →